References
- SiegelRLMillerKDJemalACancer statisticsCA Cancer J Clin201868173029313949
- ParkJCHahnNMBladder cancer: a disease ripe for major advancesClin Adv Hematol Oncol2014121283884525674841
- JamesNDHussainSAHallEBC2001 InvestigatorsRadiotherapy with or without chemotherapy in muscle-invasive bladder cancerN Engl J Med2012366161477148822512481
- GoodisonSRosserCJUrquidiVBladder cancer detection and monitoring: assessment of urine- and blood-based marker testsMol Diagn Ther2013172718423479428
- BartelDPMicroRNAs: genomics, biogenesis, mechanism, and functionCell2004116228129714744438
- HuangTAlvarezAHuBChengSYNoncoding RNAs in cancer and cancer stem cellsChin J Cancer2013321158259324206916
- ShiZWeiQZhangMSheJMicroRNAs in bladder cancer: expression profiles, biological functions, regulation, and clinical implicationsCrit Rev Eukaryot Gene Expr2014241557524579670
- FabrisLCederYChinnaiyanAMThe potential of microRNAs as prostate cancer biomarkersEur Urol201670231232226806656
- FendlerAStephanCYousefGMKristiansenGJungKThe translational potential of microRNAs as biofluid markers of urological tumoursNat Rev Urol2016131273475227804986
- DweepHGretzNmiRWalk2.0: a comprehensive atlas of microRNA-target interactionsNat Methods201512869726226356
- Huang daWShermanBTLempickiRASystematic and integrative analysis of large gene lists using DAVID bioinformatics resourcesNat Protoc200941445719131956
- SzklarczykDMorrisJHCookHThe STRING database in 2017: quality-controlled protein-protein association networks, made broadly accessibleNucleic Acids Res201745Database issueD362D36827924014
- BetelDKoppalAAgiusPSanderCLeslieCComprehensive modeling of microRNA targets predicts functional non-conserved and non-canonical sitesGenome Biol2010118R9020799968
- ShannonPMarkielAOzierOCytoscape: a software environment for integrated models of biomolecular interaction networksGenome Res200313112498250414597658
- AnayaJOncoLnc: linking TCGA survival data to mRNAs, miRNAs, and lncRNAsPeerJ Comput Sci20162e67
- FujiiTShimadaKTatsumiYmicroRNA-145 promotes differentiation in human urothelial carcinoma through down-regulation of syndecan-1BMC Cancer20151581826514209
- AvgerisMMavridisKTokasTStravodimosKFragoulisEGScorilasAUncovering the clinical utility of miR-143, miR-145 and miR-224 for predicting the survival of bladder cancer patients following treatmentCarcinogenesis201536552853725804644
- MinamiKTaniguchiKSugitoNMiR-145 negatively regulates Warburg effect by silencing KLF4 and PTBP1 in bladder cancer cellsOncotarget2017820330643307728380435
- XueMPangHLiXLiHPanJChenWLong non-coding RNA urothelial cancer-associated 1 promotes bladder cancer cell migration and invasion by way of the hsa-miR-145-ZEB1/2-FSCN1 pathwayCancer Sci20161071182726544536
- LeiMXieWSunEmicroRNA-21 regulates cell proliferation and migration and cross talk with PTEN and p53 in bladder cancerDNA Cell Biol2015341062663226230405
- ZhangLXuJYangGLiHGuoXmiR-202 inhibits cell proliferation, migration, and invasion by targeting EGFR in human bladder cancerOncol Res Epub201813
- ZhangQWangWXuWGenetic variations in the 3′-untranslated regions of genes involved in the cell cycle and apoptosis pathways affect bladder cancer riskCancer Genomics Proteomics2018151677229275364
- ZengLPHuZMLiKXiaKmiR-222 attenuates cisplatin-induced cell death by targeting the PPP2R2A/Akt/mTOR Axis in bladder cancer cellsJ Cell Mol Med201620355956726800397
- YangJLiuYHeAHsa-miR-429 promotes bladder cancer cell proliferation via inhibiting CDKN2BOncotarget2017840687216872928978151
- HuangCZengXJiangGXIAP BIR domain suppresses miR-200a expression and subsequently promotes EGFR protein translation and anchorage-independent growth of bladder cancer cellJ Hematol Oncol2017101628057023
- YangXShiLYiCYangYChangLSongDMiR-210-3p inhibits the tumor growth and metastasis of bladder cancer via targeting fibroblast growth factor receptor-like 1Am J Cancer Res2017781738175328861329
- WangJZhangXWangLMicroRNA-214 suppresses oncogenesis and exerts impact on prognosis by targeting PDRG1 in bladder cancerPLoS One2015102e011808625706919
- PapadopoulosEIScorilasACisplatin and paclitaxel alter the expression pattern of miR-143/145 and miR-183/96/182 clusters in T24 bladder cancer cellsClin Transl Sci20158666867526356996
- TsaiTFLinJFChouKYLinYCChenHEHwangTImiR-99a-5p acts as tumor suppressor via targeting to mTOR and enhances RAD001-induced apoptosis in human urinary bladder urothelial carcinoma cellsOnco Targets Ther20181123925229379304
- MoraisDRReisSTVianaNThe involvement of miR-100 in bladder urothelial carcinogenesis changing the expression levels of mRNA and proteins of genes related to cell proliferation, survival, apoptosis and chromosomal stabilityCancer Cell Int201414111925493074
- YangRLiuMLiangHmiR-138-5p contributes to cell proliferation and invasion by targeting Survivin in bladder cancer cellsMol Cancer20161518227978829
- LiDYHaoXYMaTMDaiHXSongYSThe prognostic value of platelet-to-lymphocyte ratio in urological cancers: a meta-analysisSci Rep201771538729133845
- LiDHaoXLiJDose-response relation between dietary inflammatory index and human cancer risk: evidence from 44 epidemiologic studies involving 1,082,092 participantsAm J Clin Nutr2018107337138829566194
- MeariniEPoliGCochettiGBoniAEgidiMGBrancorsiniSExpression of urinary miRNAs targeting NLRs inflammasomes in bladder cancerOnco Targets Ther2017102665267328579804
- AiJJinTYangLVinculin and filamin-C are two potential prognostic biomarkers and therapeutic targets for prostate cancer cell migrationOncotarget2017847824308243629137275
- HarleyMEAllanLASandersonHSClarkePRPhosphorylation of Mcl-1 by CDK1-cyclin B1 initiates its Cdc20-dependent destruction during mitotic arrestEMBO J201029142407242020526282
- DaiYGrantSBCL2L11/Bim as a dual-agent regulating autophagy and apoptosis in drug resistanceAutophagy201511241641825700997